Electronic Medical Record Alerts to Optimize Medical Therapy in Heart Failure and Reduced Ejection Fraction

Launched by INSTITUTO CARDIOVASCULAR DE BUENOS AIRES · Dec 4, 2023

Keywords

ClinConnect Summary

The OPTIMAL-HF trial is studying how an alert system can help doctors provide better treatment for patients with heart failure and reduced ejection fraction (HFrEF). This means the heart isn’t pumping as well as it should. The trial will compare this alert system to regular care to see if it helps doctors optimize medications within 90 days. The study will take place in an outpatient clinic in Buenos Aires, Argentina.

To be part of this trial, patients need to be over 18 years old and have a recent heart test showing their heart's pumping ability is 40% or less. Patients who are already receiving the best possible treatment or are in palliative care, which focuses on comfort rather than cure, won't be eligible. Additionally, cardiologists at the clinic will also participate in the study, but those who specialize in heart failure will not be included. Participants can expect to receive either the new alert system or usual care and will be monitored over a three-month period to see how well their treatment improves. This trial is not yet recruiting participants, but it aims to find better ways to help patients with heart failure manage their condition effectively.

Gender

ALL

Eligibility criteria

• • Patients
• Inclusion Criteria:
• • Eligible patients will include those with an EF ≤ 40% on their most recent echocardiogram, age \> 18, and an outpatient cardiology encounter during the study period.
• • Age 18 or over
• Exclusion Criteria:
• • under optimal medical treatment
• • palliative care, or undergoing hemodialysis will be excluded
• • Cardiologist
• Inclusion criteria:
• • Cardiologists from an outpatient clinic at a cardiovascular center in Buenos Aires will be selected for potential participation in the study.
• • Exclusion criteria Cardiologists belonging to the heart failure service